郑氏伤科药物结合郑氏形意拳对慢性踝关节不稳患者关节功能及疗效的影响

Zheng s injury-related drugs combined with Zheng s Xingyiquan toimprove functional limitation in patients with chronic ankle instability and its curative effect

目的:探讨郑氏伤科药物结合郑氏形意拳对慢性踝关节不稳(CAI)患者的治疗价值。方法:纳入我院2020年12月~2022年6月收治的CAI患者210例进行研究,按随机数字表法分成对照组与治疗组各105例。对照组采用超短波+郑氏形意拳治疗,治疗组采用郑氏伤科药物+郑氏形意拳治疗。比较两组治疗前后的中医症状评分、疼痛视觉模拟评分(VAS)、美国足踝协会(AOFAS)踝-后足评分及踝关节肌力指标,包括背屈峰力矩(DPT)、跖屈峰力矩(PPT)、背屈总功(DTW)、跖屈总功(PTW),评估总体疗效,比较两组不良反应。结果:两组治疗后踝部疼痛、瘀斑肿胀、踝部功能受限评分低于治疗前,且治疗组低于对照组(P<0.05)。两组治疗1、3、6个月VAS评分低于治疗前,且治疗组低于常规组,两组治疗1、3、6个月AOFAS评分高于治疗前,且治疗组高于常规组(P<0.05)。两组治疗后DPT、PPT、DTW、PTW高于治疗前,且治疗组高于对照组(P<0.05)。治疗组(95.24%)总有效率高于对照组(84.76%)(P<0.05)。对照组无患者出现不良反应,治疗组不良反应率为3.81%,两组比较无差异(P>0.05)。结论:郑氏伤科药物结合郑氏形意拳能改善CAI患者的关节功能与踝关节肌力,总体疗效良好,安全性高。

Objective:To explore the therapeutic value of Zheng s medicine combined with Zheng s Xingyiquan in the treatment of chronic ankle instability(CAI).Methods:A total of 210CAI patients admitted to our hospital from December 2020to June 2022were included in the study,and were divided into control group and treatment group with 105cases in each group according to random number table method.The control group was treated with ultra-short wave combined with Zheng s Xingyi boxing,and the treatment group was treated with Zheng s traumatology drugs combined with Zheng s Xingyi boxing.Chinese medicine symptom score,visual analogue scale(VAS),American orthopaedic foot and ankle society(AOFAS)ankle-posterior foot score and ankle muscle strength indexes,including peak torque of dorsiflexion(DPT),peak torque of plantarflexion(PPT),total work of dorsiflexion(DTW)and total work of plantarflexion(PTW),were compared between the two groups before and after treatment to evaluate the overall efficacy.The adverse reactions of the two groups were compared.Results:The scores of ankle pain,ecchymosis swelling and ankle functional limitation after treatment were lower than those before treatment,and the scores of treatment group were lower than those of control group(P<0.05).VAS scores at 1,3and 6months of treatment in two groups were lower than before treatment,and the treatment group was lower than the conventional group,and AOFAS scores at 1,3and 6months of treatment in two groups were higher than before treatment,and the treatment group was higher than the conventional group(P<0.05).DPT,PPT,DTW and PTW after treatment were higher than before treatment,and the treatment group was higher than the control group(P<0.05).The total effective rate of treatment group(95.24%)was higher than that of control group(84.76%)(P<0.05).The control group had no adverse reactions,while the treatment group had an adverse reaction rate of 3.81%,with no significant difference between the two groups(P>0.05).Conclusion:Zheng s injury-related drugs combined with Zheng s Xingyiquan can improve the joint function and ankle muscle strength of CAI patients,with good overall efficacy and high safety.